ANI Pharmaceuticals is a diversified biopharmaceutical company that develops, manufactures, and commercializes therapeutics across Rare Disease, Generics, and Brands to serve patients and improve lives.

# ANI Pharmaceuticals

## Overview
ANI Pharmaceuticals is a diversified biopharmaceutical company.

## Mission
"Serving Patients, Improving Lives" by developing, manufacturing, and commercializing therapeutics.

## Business focus
Operates through three core areas:
- Rare Disease
- Generics
- Brands

## Recent development
On September 16, 2024, ANI Pharmaceuticals acquired Alimera Sciences, Inc. As part of the acquisition, the company added two products: ILUVIEN® and YUTIQ®.

## Disclosures
See Note 3, "Business Combination," in the notes to the consolidated financial statements for details of the acquisition and its impact.

ANI PHARMACEUTICALS INC

10-K / February 27, 2026

ANI Pharmaceuticals

Overview

Mission

Business focus

Recent development

Disclosures